Virginia Retirement Systems Et Al Immuno Gen, Inc. Transaction History

Virginia Retirement Systems Et Al

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 22, 2023	BUY	$3.75 - $20.05 $50,625 - $270,675	13,500 New	13,500 $254,000
Q3 2022 May 16, 2023	BUY	$4.48 - $6.47 $72,128 - $104,167	16,100 New	16,100 $77 Million
Q1 2022 Apr 21, 2022	SELL	$4.26 - $7.48 $43,452 - $76,296	-10,200 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$4.75 - $7.5 $48,450 - $76,500	10,200 New	10,200 $76,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.